Summary of Product Characteristics
last updated on the eMC:
29/10/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 29/10/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 01-Feb-2008 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
Changes to:
Section 4.1 (Therapeutic indications), rheumatic pains, migraine, neuralgia, toothache, sore throat, discomfort associated with influenza, feverishness and feverish colds were all removed.
Section 4.8 (undesirable effects), constipation added as a potential side effect.
|
|
Updated on 18/09/2006 and displayed until 29/10/2009
|
Reasons for adding or updating:
|
|
|
|